Founded in 2000
Financial data: €1.11B Market Cap (on 26/11/2015)
Basilea develops and commercializes innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections, and oncology.
Labiotech UG, All Rights Reserved -
Send this to friend